Dazhi Liu

4PUBLICATIONS
34CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 27, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

|Apr 03, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.

Dazhi Liu, Justin Jee, Alexander Drilon

|Feb 25, 2022
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment.

Dazhi Liu, Michael A Weintraub, Christine Garcia

|Jan 18, 2021
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City.

Prakirthi Yerram, Jennifer Thackray, Lisa R Modelevsky

Pageof 1

Frequent Collaborators

2 joint publications

Alexander Drilon

2 joint publications

Bob T Li

1 joint publications

Michael J Buege

1 joint publications

James J Harding